SCHEMBL418323

SCHEMBL418323

O=C(O)CC(OCc1ccccc1)(OCc1ccccc1)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.47
SLC6A2 P23975 1/20 0.47
SLC6A3 Q01959 1/20 0.47
KMT2A Q03164 1/20 0.47
ALDH1A1 P00352 4/20 0.44
LMNA P02545 1/20 0.43
MAPK1 P28482 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
AKR1B1 P15121 1/20 0.42
HTT P42858 1/20 0.41
HIF1A Q16665 2/20 0.40
TSHR P16473 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
FFAR1 O14842 1/20 0.40
FFAR4 Q5NUL3 1/20 0.40
CYP2C19 P33261 1/20 0.40
POLB P06746 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
NR4A1 P22736 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8534989 0.84 NPC1 (0.42) KMT2AALDH1A1MAPK1L3MBTL1FFAR1
SCHEMBL423042 0.82 ALOX5 (0.42) TDP1SLC6A2SLC6A3KMT2AALDH1A1
SCHEMBL1653920 0.79 LTA4H (0.45) ALDH1A1MAPK1L3MBTL1HIF1ASMN1; SMN2
SCHEMBL24361875 0.78 KMT2A (0.47) TDP1SLC6A2SLC6A3KMT2AALDH1A1
SCHEMBL673676 0.77 HIF1A (0.44) TDP1SLC6A2SLC6A3KMT2AALDH1A1
SCHEMBL16430301 0.76 CYP2C19 (0.47) TDP1SLC6A2SLC6A3KMT2AALDH1A1
SCHEMBL16107130 0.76 TDP1 (0.42) TDP1SLC6A2SLC6A3KMT2AALDH1A1
SCHEMBL1653919 0.75 TDP1 (0.49) TDP1SLC6A2SLC6A3KMT2AALDH1A1
SCHEMBL9141654 0.75 ALDH1A1 (0.46) TDP1SLC6A2SLC6A3KMT2AALDH1A1
SCHEMBL27677158 0.75 SLC13A5 (0.47) TDP1SLC6A2SLC6A3KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150252039-A1 Process For The Preparation Of Pyrido[2,1-a] Isoquinoline Derivatives By Catalytic Asymmetric Hydrogenation Of An Enamine HOFFMANN-LA ROCHE INC. 2015-09-10 US disclosed
US-20150126743-A1 Process For The Preparation Of Pyrido [2,1-A] Isoquinoline Derivatives Comprising Optical Resolution Of An Enamine HOFFMANN-LA ROCHE INC. 2015-05-07 US disclosed
US-20150031888-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE F. HOFFMANN-LA ROCHE AG (CH) 2015-01-29 US disclosed
US-20140187785-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE HOFFMANN-LA ROCHE INC. (US) 2014-07-03 US disclosed
US-20130338366-A1 PROCESS FOR THE PREPARATION OF PYRIDO [2,1-A] ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE HOFFMANN LA ROCHE (US) 2013-12-19 US disclosed
US-20130109859-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE HOFFMANN-LA ROCHE INC. (US) 2013-05-02 US disclosed
US-20130018191-A1 PROCESS FOR THE PREPARATION OF PYRIDO [2,1-A] ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE ABRECHT STEFAN (CH) 2013-01-17 US disclosed
US-20120022260-A1 PROCESS FOR THE PREPARATION OF PYRIDO [2,1-a] ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE ABRECHT STEFAN (CH) 2012-01-26 US disclosed
US-20120010413-A1 Process for the Preparation of Pyrido [2,1-a] Isoquinoline Derivatives by Catalytic Asymmetric Hydrogenation of an Enamine ABRECHT STEFAN (CH) 2012-01-12 US disclosed
EP-2066667-B1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-A]ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE HOFFMANN LA ROCHE (CH) 2011-08-31 EP disclosed
EP-2069343-A2 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-A]ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE F. Hoffmann-Roche AG (CH) 2009-06-17 EP disclosed
EP-2066667-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-A]ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE F. Hoffmann-Roche AG (CH) 2009-06-10 EP disclosed
US-20080076925-A1 PROCESS FOR THE PREPARATION OF PYRIDO [ 2-1-A] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE F. HOFFMANN-LA ROCHE AG (CH) 2008-03-27 US disclosed
WO-2008031749-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-A]ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE F. HOFFMANN-LA ROCHE AG (CH) 2008-03-20 WO disclosed
US-20080071087-A1 PROCESS FOR THE PREPARATION OF PYRIDO [2,1-a] ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE HOFFMAN-LA ROCHE INC. 2008-03-20 US disclosed
WO-2008031750-A2 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-A]ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE F. HOFFMANN-LA ROCHE AG (CH) 2008-03-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080076925-A1 PROCESS FOR THE PREPARATION OF PYRIDO [ 2-1-A] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE PNISR, SFPQ, PLPBP TDP1 4630/4885SLC6A2 3683/4885SLC6A3 4020/4885
US-20130109859-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE IDO2, IDO1, H1-2 TDP1 3980/4885SLC6A2 3752/4885SLC6A3 3651/4885
US-20150031888-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE IDO2, IDO1, H1-2 TDP1 3980/4885SLC6A2 3752/4885SLC6A3 3651/4885
US-20130018191-A1 PROCESS FOR THE PREPARATION OF PYRIDO [2,1-A] ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE PNPO, ENO1, CHRM1 TDP1 2415/4885SLC6A2 1004/4885SLC6A3 3122/4885
US-20130338366-A1 PROCESS FOR THE PREPARATION OF PYRIDO [2,1-A] ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE PNPO, ENO1, CHRM1 TDP1 2415/4885SLC6A2 1004/4885SLC6A3 3122/4885
US-20120022260-A1 PROCESS FOR THE PREPARATION OF PYRIDO [2,1-a] ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE PNPO, ENO1, CHRM1 TDP1 2415/4885SLC6A2 1004/4885SLC6A3 3122/4885
US-20120010413-A1 Process for the Preparation of Pyrido [2,1-a] Isoquinoline Derivatives by Catalytic Asymmetric Hydrogenation of an Enamine IDO2, IDO1, H1-2 TDP1 3980/4885SLC6A2 3752/4885SLC6A3 3651/4885
US-20150252039-A1 Process For The Preparation Of Pyrido[2,1-a] Isoquinoline Derivatives By Catalytic Asymmetric Hydrogenation Of An Enamine IDO2, IDO1, H1-2 TDP1 3980/4885SLC6A2 3752/4885SLC6A3 3651/4885
US-20150126743-A1 Process For The Preparation Of Pyrido [2,1-A] Isoquinoline Derivatives Comprising Optical Resolution Of An Enamine PNPO, ENO1, CHRM1 TDP1 2415/4885SLC6A2 1004/4885SLC6A3 3122/4885
US-20140187785-A1 PROCESS FOR THE PREPARATION OF PYRIDO[2,1-a] ISOQUINOLINE DERIVATIVES BY CATALYTIC ASYMMETRIC HYDROGENATION OF AN ENAMINE IDO2, IDO1, H1-2 TDP1 3980/4885SLC6A2 3752/4885SLC6A3 3651/4885
US-20080071087-A1 PROCESS FOR THE PREPARATION OF PYRIDO [2,1-a] ISOQUINOLINE DERIVATIVES COMPRISING OPTICAL RESOLUTION OF AN ENAMINE PNPO, ENO1, CHRM1 TDP1 2415/4885SLC6A2 1004/4885SLC6A3 3122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.